Sun Pharma delivered strong YOY growth triggered by domestic & US markets | Q2FY22 Result & Earning Call Highlights
Published on 12 November 2021 .Views 12.Comments 0
Share On
Company reported strong YOY growth led by India & US formulation business whereas on QOQ basis these markets degree but the degrowth was offset by growth in Emerging & Rest of the World Markets.
Download
